Romy N. Bouwmeester

Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study

Romy N. Bouwmeester, Caroline Duineveld, Kioa L. Wijnsma et al. · Kidney International Reports · 2022 · 41 citations · Full text

Euthanasia requests in dementia cases; what are experiences and needs of Dutch physicians? A qualitative interview study

Jaap Schuurmans, Romy N. Bouwmeester, Lamar Crombach et al. · BMC Medical Ethics · 2019 · 35 citations · Full text

COVID-19 vaccination and Atypical hemolytic uremic syndrome

Romy N. Bouwmeester, Esther M.G. Bormans, Caroline Duineveld et al. · Frontiers in Immunology · 2022 · 19 citations · Full text

Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum

David Kavanagh, Gianluigi Ardissino, Vicky Brocklebank et al. · Kidney International · 2024 · 16 citations · Full text

The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS

Wouter J. C. Feitz, Romy N. Bouwmeester, Thea J. A. M. van der Velden et al. · Microorganisms · 2021 · 15 citations · Full text